BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7859878)

  • 1. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Gillis S; Dann EJ; Eldor A
    Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
    Barbui T; Finazzi G; Falanga A
    Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombosis and DIC in hematological malignancies].
    Asakura H
    Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disseminated intravascular coagulation in malignant neoplasms].
    Kato A
    Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical observation of low dose of heparin to treat coagulation disorders of acute promyelocytic leukemia].
    Chen S; Chen S; Yu Y; Chen J; Guo Y; Xu L; Zhang K; Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):459-60. PubMed ID: 24857222
    [No Abstract]   [Full Text] [Related]  

  • 8. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin III in the acute promyelocytic leukemias].
    Roncalés FJ; Juncá J; Tuset E
    Sangre (Barc); 1994 Apr; 39(2):148-9. PubMed ID: 8059294
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.
    Tallman MS; Kwaan HC
    Blood; 1992 Feb; 79(3):543-53. PubMed ID: 1732003
    [No Abstract]   [Full Text] [Related]  

  • 14. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complete remission of acute promyelocytic leukemia accompanied by DIC in an elderly patient treated with all-trans retinoic acid].
    Handa H; Jinbo T; Okamoto K; Hirabayashi H; Miyawaki S
    Nihon Ronen Igakkai Zasshi; 1993 Feb; 30(2):146-9. PubMed ID: 8483289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
    Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
    Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging.
    Cahill TJ; Chowdhury O; Myerson SG; Ormerod O; Herring N; Grimwade D; Littlewood T; Peniket A
    Circulation; 2011 Mar; 123(10):e370-2. PubMed ID: 21403118
    [No Abstract]   [Full Text] [Related]  

  • 19. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Tallman MS; Manji GA
    Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.